Dietmar Enko
Overview
Explore the profile of Dietmar Enko including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
96
Citations
573
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Enko D
Clin Lab
. 2025 Mar;
71(3).
PMID: 40066539
Background: The essential trace element iron, which can occur in various oxidation states, is required for many biochemical reactions and processes in the human body. Methods: This review summarizes the...
2.
Enko D, Meinitzer A, Dawczynski C, Zelzer S, Pilz S, Niedrist T, et al.
Clin Lab
. 2025 Mar;
71(3).
PMID: 40066537
No abstract available.
3.
Schnedl W, Leixner G, Voill-Glaninger A, Michaelis S, Enko D, Mangge H
Ann Hematol
. 2025 Feb;
PMID: 40016398
Hemoglobinopathies are among the most common inherited diseases and they are believed to be one of the major etiologic factors contributing to anemia. Thalassemia is characterized by an altered hemoglobin...
4.
Baranyi A, Meinitzer A, von Lewinski D, Wagner-Skacel J, Garcia S, Rothenhausler H, et al.
Sci Rep
. 2025 Jan;
15(1):1520.
PMID: 39789030
Early depressive symptoms within the first days after acute myocardial infarction (AMI) are mainly manifested with performance parameters (lack of energy, concentration difficulties, reduction in physical functioning). Homoarginine (hArg), a...
5.
Michaelis S, Hochfellner A, Schneider C, Schnedl W, Baranyi A, Enko D
Clin Chem Lab Med
. 2024 Jul;
63(1):139-146.
PMID: 38986473
Objectives: Fecal calprotectin (FC) serves as a non-invasive marker for the assessment of gut inflammation in patients with inflammatory bowel disease (IBD). Laboratory measurements are usually performed with immunologic methods...
6.
Almer G, Enko D, Kartiosuo N, Niinikoski H, Lehtimaki T, Munukka E, et al.
Clin Chem
. 2024 Jun;
70(9):1162-1171.
PMID: 38906833
Background: Primary prevention is the cornerstone of cardiometabolic health. In the randomized, controlled Special Turku Coronary Risk Factor Intervention Project (STRIP), dietary counseling intervention was given to children from infancy...
7.
Herrmann M, Keppel M, Zelzer S, Alonso N, Cavalier E, Kleber M, et al.
Clin Chem Lab Med
. 2024 Jun;
63(1):208-219.
PMID: 38890759
Objectives: The role of vitamin D deficiency in cardiovascular disease (CVD) is controversial. Inherent biological and analytical limitations compromise the specificity of widely used 25-hydroxyvitamin D [25(OH)D] cut-offs. Simultaneous determination...
8.
Schnedl W, Michaelis S, Mangge H, Enko D
Endocrine
. 2024 Apr;
86(1):233-238.
PMID: 38635065
Purpose: Recommended pharmacotherapy for hypothyroidism in Hashimoto's thyroiditis (HT) is oral supplementation with levothyroxine (LT-4). However, serum thyrotropin (TSH) levels within normal range are not consistently achieved with LT-4 medication....
9.
Zelzer S, Meinitzer A, Enko D, Keppel M, Herrmann M, Theiler-Schwetz V, et al.
Nutrients
. 2024 Mar;
16(6).
PMID: 38542750
Circulating 25-hydroxyvitamin D (25(OH)D) is the generally accepted indicator of vitamin D status. Since hydroxylation of 25(OH)D to 24-25-dihydroxyvitamin D (24,25(OH)2D) is the first step of its catabolism, it has...
10.
Zelzer S, Meinitzer A, Enko D, Markis K, Tournis S, Trifonidi I, et al.
Clin Chem Lab Med
. 2023 Dec;
62(7):1402-1410.
PMID: 38158723
Objectives: Vitamin D and K are believed to promote bone health, but existing evidence is controversial. This study aimed to measure several metabolites of both vitamins by liquid chromatography tandem...